article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

Flash back to my article for the Society for Participatory Medicine last year: Let’s Save the Date and Make Patient Engagement Official in 2022. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen.

BioTech 144
article thumbnail

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Digital Health Global

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners.

BioTech 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally.

article thumbnail

How Technology Can Help Overcome Barriers to Getting Effective Therapies into Patients with Ultra Rare Disorders

Healthcare IT Today

The following is a guest article by Dr. Zach Landman, Co-Founder of Moonshots for Unicorns. As we saw with COVID, when treatments were needed more rapidly than the typical drug development timeline could offer, we identified existing medicines that could be repurposed (such as remdesevir and dexamethasone, among many others.)